Vaiva G, Boss V, Bailly D, Thomas P, Lestavel P, Goudemand M
Department of Psychiatry, CHRU de Lille, Université de Lille II, France.
J Psychoactive Drugs. 2001 Jan-Mar;33(1):95-8. doi: 10.1080/02791072.2001.10400473.
Over the last 10 years, Europe has witnessed the development of the ecstasy phenomenon; this term is used to describe several products sharing more or less the same effects. The most widely used and hence the most well known is 3,4 MDMA, but MDA, MDEA, MBDB and even 2CB or nexus are available. The psychopathological consequences of MDMA use in man are relatively poorly understood. The case reported here involves an acute psychotic episode with residual symptoms after six months, with a sudden onset at least 12 hours after taking alcohol and ecstasy without realising it, in an individual with no previous psychopathology other than a moderate anxiety disorder. Twelve cases of acute psychotic episodes after taking ecstasy have been reported in the literature; two after taking the drug on two occasions and one after a single use. No authors have examined the previous mental state or possible previous psychopathology with any precision. The present subject had not displayed any previous psychotic behavior when tested with a proven standardized interview technique; this was confirmed by his peers and his family. He did, however, show signs of social phobia. Although the personality of an individual is a factor in taking a drug, and probably in the quality of the psychotropic effects experienced, a host of arguments favor the appearance of psychotic symptoms de novo, which were probably related to direct toxicity by MDMA and/or its metabolites on the serotoninergic neurons.
在过去十年里,欧洲见证了摇头丸现象的发展;这个术语用于描述几种或多或少具有相同效果的产品。使用最广泛且因此最为人所知的是3,4-亚甲基二氧甲基苯丙胺(MDMA),但也有3,4-亚甲基二氧苯丙胺(MDA)、3,4-亚甲基二氧乙基苯丙胺(MDEA)、1-甲基-3,4-亚甲基二氧苯丙胺(MBDB),甚至2,5-二甲氧基-4-溴苯乙胺(2CB)或nexus等。人们对MDMA在人体中的精神病理学后果了解相对较少。本文报告的病例是一名既往除中度焦虑症外无其他精神病理学问题的个体,在不知不觉中饮酒和服用摇头丸至少12小时后突然发病,出现急性精神病性发作,六个月后仍有残留症状。文献中已报道了12例服用摇头丸后出现急性精神病性发作的病例;其中2例是在两次服药后发病,1例是单次服药后发病。此前没有作者精确研究过这些患者之前的精神状态或可能存在的既往精神病理学问题。使用经过验证的标准化访谈技术对本病例进行测试时,他此前未表现出任何精神病行为;他的同龄人及家人也证实了这一点。不过,他确实表现出社交恐惧症的迹象。虽然个体的人格是服用药物的一个因素,可能也与所体验到的精神药物作用的性质有关,但大量论据支持精神病症状是从头出现的,这可能与MDMA和/或其代谢产物对5-羟色胺能神经元的直接毒性有关。